Eurofins Scientific SE
ERFSFOTCHealthcare● Active
$72.60
$-3.39(-4.46%)
Market Cap$12.7B
P/E Ratio—
52W High$86.2
52W Low$63.96
Eurofins Scientific SE (ERFSF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ERFSF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Jan 29, 2026EPS Actual
$1.50
Est. $1.48 · +1.4%
Revenue
$4.33B
Est. $4.33B · -0.2%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Jan 29, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
ERFSF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.02
Rev. $0.33B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.02
Rev. Est.$0.33B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $2.23 | — | — | — | $4.28B | — |
| ▲ Q1 FY2026 | Jan 29, 2026 | $1.48 | $1.50 | +1.4% | $4.33B | $4.33B | -0.2% |
| ▼ Q2 FY2025 | Jun 30, 2025 | $2.01 | $1.54 | -23.4% | $4.25B | $4.26B | -0.3% |
| ▼ Q4 FY2024 | Dec 31, 2024 | $1.54 | $0.99 | -35.8% | $3.66B | $3.68B | -0.6% |
| ▼ Q2 FY2024 | Jun 29, 2024 | $1.59 | $1.22 | -23.3% | $3.68B | $3.72B | -1.1% |
| ▼ Q4 FY2023 | Dec 30, 2023 | $1.32 | $0.88 | -33.0% | $3.63B | $3.69B | -1.4% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $1.38 | $0.83 | -39.6% | $3.50B | $3.50B | -0.0% |
| ▲ Q4 FY2022 | Dec 31, 2022 | $1.59 | $1.63 | +2.5% | $3.56B | $3.60B | -1.3% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$2.23
EPS Surpr.
—
Revenue
—
Q1 FY2026
Jan 29, 2026Beat
EPS Actual
$1.50
EPS Est.
$1.48
EPS Surpr.
+1.4%
Revenue
$4.33B
Q2 FY2025
Jun 30, 2025Miss
EPS Actual
$1.54
EPS Est.
$2.01
EPS Surpr.
-23.4%
Revenue
$4.25B
Q4 FY2024
Dec 31, 2024Miss
EPS Actual
$0.99
EPS Est.
$1.54
EPS Surpr.
-35.8%
Revenue
$3.66B
Q2 FY2024
Jun 29, 2024Miss
EPS Actual
$1.22
EPS Est.
$1.59
EPS Surpr.
-23.3%
Revenue
$3.68B
Q4 FY2023
Dec 30, 2023Miss
EPS Actual
$0.88
EPS Est.
$1.32
EPS Surpr.
-33.0%
Revenue
$3.63B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$0.83
EPS Est.
$1.38
EPS Surpr.
-39.6%
Revenue
$3.50B
Q4 FY2022
Dec 31, 2022Beat
EPS Actual
$1.63
EPS Est.
$1.59
EPS Surpr.
+2.5%
Revenue
$3.56B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $1.6B | $1.6B | $1.6B | 1 |
| Q4 FY2025 | $1.6B | $1.6B | $1.6B | 1 |
| Q3 FY2025 | $1.5B | $1.5B | $1.5B | 1 |
| Q1 FY2025 | $1.6B | $1.6B | $1.6B | 2 |
| Q4 FY2024 | $1.6B | $1.6B | $1.6B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Jan 29, 2026 | +1.4% | $83.00 | $81.05 | -2.35% |
| ▼ Q2 FY2025 | Jun 30, 2025 | -23.4% | $71.50 | $71.74 | +0.34% |
| ▼ Q4 FY2024 | Dec 31, 2024 | -35.8% | $49.49 | $52.46 | +6.00% |
| ▼ Q2 FY2024 | Jun 29, 2024 | -23.3% | $48.90 | $48.79 | -0.22% |
| ▼ Q4 FY2023 | Dec 30, 2023 | -33.0% | $64.31 | $65.02 | +1.10% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -39.6% | $59.33 | $65.01 | +9.57% |
| ▲ Q4 FY2022 | Dec 31, 2022 | +2.5% | $72.39 | $69.86 | -3.49% |
| ▼ Q4 FY2022 | Oct 18, 2022 | -21.0% | $58.00 | $60.00 | +3.45% |
Q1 FY2026-2.35%
Report Date
Jan 29, 2026
EPS Beat/Miss
+1.4%
Price Before
$83.00
Price After
$81.05
Q2 FY2025+0.34%
Report Date
Jun 30, 2025
EPS Beat/Miss
-23.4%
Price Before
$71.50
Price After
$71.74
Q4 FY2024+6.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
-35.8%
Price Before
$49.49
Price After
$52.46
Q2 FY2024-0.22%
Report Date
Jun 29, 2024
EPS Beat/Miss
-23.3%
Price Before
$48.90
Price After
$48.79
Q4 FY2023+1.10%
Report Date
Dec 30, 2023
EPS Beat/Miss
-33.0%
Price Before
$64.31
Price After
$65.02
Q2 FY2023+9.57%
Report Date
Jun 30, 2023
EPS Beat/Miss
-39.6%
Price Before
$59.33
Price After
$65.01
Q4 FY2022-3.49%
Report Date
Dec 31, 2022
EPS Beat/Miss
+2.5%
Price Before
$72.39
Price After
$69.86
Q4 FY2022+3.45%
Report Date
Oct 18, 2022
EPS Beat/Miss
-21.0%
Price Before
$58.00
Price After
$60.00
Avg Beat Reaction-2.92%
Avg Miss Reaction+3.37%
Beat Rate2 / 8 quarters
Largest Move+9.57% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ERFSF ends December
Eurofins Scientific SE (ERFSF) most recently reported earnings on January 29, 2026 for Q1 FY2026, posting EPS of $1.50 — beating the analyst consensus of $1.48 by +1.4%. The next ERFSF earnings date is expected around September 1, 2026.
Each quarter, investors track ERFSF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ERFSF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ERFSF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ERFSF earnings · 5 questionsEurofins Scientific SE's next earnings report is expected around September 1, 2026. ERFSF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ERFSF historically reports after market close (AMC).
ERFSF earnings datewhen is ERFSF earningsERFSF next earnings datewhen does ERFSF report earningsERFSF earnings calendar
▸ Source: FMP · Eurofins Scientific SE SEC filings · US GAAP · Eurofins Scientific SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026